Shareholder Alert: Ademi LLP investigates whether Akouos, Inc. has obtained a Fair Price in its transaction with Eli Lilly
prnewswire.com
news
2022-10-18 14:35:00

MILWAUKEE, Oct. 18, 2022 /PRNewswire/ -- Ademi LLP is investigating Akouos (NASDAQ: AKUS) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli Lilly. 
Click here to learn how to join the action https://www.ademilaw.com/case/akouos-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.
Ademi LLP alleges Akouos' financial outlook and prospects are excellent and yet Akouos holders will receive only $12.50 per share in cash (an aggregate of approximately $487 million) payable at closing plus one non-tradeable contingent value right per share that entitles the holder to receive up to an additional $3.
